Antipsychotic poisoning in young children: a systematic review

Geoffrey K Isbister1, Corrine R Balit, Henry A Kilham

  • 1Tropical Toxinology Unit, Menzies School for Health Research, Sydney, Australia. geoffrey.isbister@menzies.edu.au

Drug Safety
|October 20, 2005
PubMed

Insights

Unintentional antipsychotic poisoning in children can cause severe, prolonged effects, even from a single tablet. Prompt medical assessment is crucial for symptomatic children, with most recovering well with supportive care.

Area of Science:

  • Toxicology
  • Pediatrics
  • Pharmacology

Background:

  • Unintentional antipsychotic poisoning in children is a significant concern.
  • Limited data exists on the spectrum and severity of these poisonings.

Purpose of the Study:

  • To determine the spectrum and severity of effects from unintentional antipsychotic poisoning in children aged 0-6 years.
  • To estimate toxic doses for various antipsychotic medications.

Main Methods:

  • Comprehensive literature search of MEDLINE, EMBASE, and the internet.
  • Hand search of proceedings from NACCT and EAPCCT.
  • Inclusion of all reported cases of unintentional antipsychotic poisoning in children (0-6 years).

Main Results:

  • Sixty-eight reports were identified, with data often incomplete.
  • Most antipsychotic ingestions caused severe symptoms lasting 1-3 days, sometimes from a single tablet.
  • Extrapyramidal symptoms (EPS) were common, often delayed; specific toxic doses were estimated for chlorpromazine, haloperidol, thioridazine, clozapine, olanzapine, and aripiprazole.

Conclusions:

  • Unintentional antipsychotic ingestion in children can lead to severe, prolonged effects.
  • Hospital assessment is recommended for symptomatic children or those ingesting potentially toxic doses.
  • Most cases resolve with supportive care, but toxic dose estimates require cautious interpretation due to limited data.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...